1st Canadian PubCo to “Complete Legal Harvest of Psilocybe Mushrooms”
Dave Jackson Dave Jackson, Stockhouse
0 Comments| 12 hours ago
0
+ Favourites
In a recent Stockhouse podcast, many of our investor audiences were introduced to a new Company that’s advancing psychedelic laboratory testing, therapy, and research, with an ultimate purpose of delivering the highest quality outcomes to their clients.
Today, Numinus Wellness Inc. (NUMI) (TSX-V.NUMI, OTCMKTS: LKYSF, Forum) is at the scientific forefront of developing safe, evidence-based psychedelic-assisted psychotherapies and other transformative and supportive health solutions. The Company says that it is “creating an ecosystem of health solutions” aimed at advancing psychedelic laboratory testing, therapy, and clinical research.
Also known as ‘magic mushrooms’, psilocybin and psilocybin-assisted psychotherapy are currently being studied as treatments for a wide range of mental health conditions including depression, anxiety, and substance use disorders. NUMI just made a giant leap forward for the entire psychedelic industry.
